Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3 8‐week multicenter double‐blind randomized controlled study

摘要

To report the efficacy and safety of blonanserin in patients with schizophrenia compared with risperidone in a Japanese multicenter, randomized, double‐blind study based on post hoc sensitivity analysis in addition to the previous results reported by Miura and discuss the current approaches for schizophrenia treatment.